Advertisement

DNA-Based Immunization Against Hepatitis B: Experience with Animal Models

  • H. L. Davis
Chapter
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 226)

Abstract

Infection with the hepatitis B virus (HBV) continues to present a worldwide health problem. Whether the escalating infection and disease will eventually be controlled depends largely on the widespread availability of safe, effective and affordable vaccines (Purcell 1994).

Keywords

Direct Gene Transfer Virus Surface Antigen Subviral Particle Peak Antibody Titer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C (1985) Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 230:1160–1163PubMedCrossRefGoogle Scholar
  2. Buendia MA (1992) Hepatitis B viruses and hepatocellular carcinoma. Adv Cancer Res 59:167–226PubMedCrossRefGoogle Scholar
  3. Centers for Disease Control (1987) Recommendations of the immunization practises advisory committee. Update on hepatitis B prevention. MMWR 36:353Google Scholar
  4. Davis, HL, Brazolot Millan CL, Watkins SC (1997) Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA. Gene Ther 4:181–188PubMedCrossRefGoogle Scholar
  5. Davis HL, Demeneix BA, Quantin B, Coulombe J, Whalen RG (1993) Plasmid DNA is superior to viral vectors for direct gene transfer in adult mouse skeletal muscle. Human Gene Ther 4:733–740CrossRefGoogle Scholar
  6. Davis HL, Mancini M, Michel M-L, Whalen RG (1996) DNA-mediated immunization to hepatitis B surface antigen: Longevity of primary response and effect of boost. Vaccine 14:910–915PubMedCrossRefGoogle Scholar
  7. Davis HL, McCluskie MJ, Gerin JL, Purcell RH (1996) DNA vaccine for hepatitis B: immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 93:7213–7218PubMedCrossRefGoogle Scholar
  8. Davis HL, Michel M-L, Mancini M, Schleef M, Whalen RG (1994) Direct gene transfer in muscle with plasmid DNA for the purpose of nucleic acid immunization. Vaccine 12:1503–1509PubMedCrossRefGoogle Scholar
  9. Davis HL, Michel M-L, Whalen RG (1993) DNA based immunization for hepatitis B induces continuous secretion of antigen and high levels of circulating antibody. Hum Molec Genet 2:1847–1851PubMedCrossRefGoogle Scholar
  10. Davis HL, Michel M-L, Whalen RG(1995) Use of plasmid DNA for direct gene transfer and immunization. NY Acad Sci 772:21–29CrossRefGoogle Scholar
  11. Davis HL, Schirmbeck R, Reimann J, Whalen RG (1995) DNA-mediated immunization in mice induces a potent MHC class-I restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther, 6:1447–1456PubMedCrossRefGoogle Scholar
  12. Davis HL, Whalen RG, Demeneix BA (1993) Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum Gene Ther 4:151–159PubMedCrossRefGoogle Scholar
  13. Ellis RW (ed) (1993) Hepatitis B vaccines in clinical practise. Marcel Dekker, New YorkGoogle Scholar
  14. Ganem D, Varmus HE (1987) The molecular biology of the hepatitis B viruses. Ann Rev Biochem 56:651–693PubMedCrossRefGoogle Scholar
  15. Gerin JL, Purcell RH, Lerner RA (1985) Use of synthetic peptides to identify protective epitopes of the hepatitis B surface antigen. In: R Lerner, F Brown and R Chanock (eds) Vaccines 85: Modern approaches to vaccines. Molecular and chemical basis of resistance to viral, bacterial and parasitic diseases. Cold Spring Harbour Laboratory, Cold Spring Harbour, New York pp 235–239Google Scholar
  16. Iwarson S, Tabor E, Thomas HC, Goodall A, Waters J, Snoy P, Shih JWK, Gerety RJ (1985) Neutralization of hepatitis B virus infectivity by a murine monoclonal antibody: an experimental study in the chimpanzee. J Med Virol 16:89–96PubMedCrossRefGoogle Scholar
  17. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B-cell activation, Nature, 374:546–549PubMedCrossRefGoogle Scholar
  18. Kruskall MS, Alper CA, Awdeh Z, Yunis EJ, Marcus-Bagley D (1992) The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 175:495–502PubMedCrossRefGoogle Scholar
  19. Lubeck MD, Davis AR, Chengalvala M, Natuk RJ, Morin JE, Molnar-Kimber K, Mason BB, Bhat B M, Mizutani S, Hung PP, Purcell RH (1989) Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus. Proc Natl Acad Sci USA 86:6763–6767PubMedCrossRefGoogle Scholar
  20. Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel ML (1996) DNA-mediated immunization breaks tolerance in a transgenic mouse model of hepatitis B surface antigen chronic carriers. Proc Natl Acad Sci USA 93:12496–12501PubMedCrossRefGoogle Scholar
  21. Mancini M, Hadchouel M, Tiollais P, Pourcel C, Michel ML (1993) Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing “nonresponse” to HBsAg. J Med Virol 39:67–74PubMedCrossRefGoogle Scholar
  22. Maugh TH (1980) Hepatitis B vaccine passes first major test. Science 210:760–762PubMedCrossRefGoogle Scholar
  23. Maupas P, Goudeau A, Coursaget P, Drucker J (1976) Immunization against hepatitis B in man. Lancet 1:1367–1370PubMedCrossRefGoogle Scholar
  24. Michel ML, Pontisso P, Sobczak E, Malpièce Y, Streeck RE, Tiollais P (1984) Synthesis in animal cells of hepatitis B surface antigen particles carrying a receptor for polymerized human serum albumin. Proc Natl Acad Sci USA 81:7708–7712PubMedCrossRefGoogle Scholar
  25. Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG (1995) DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc Natl Acad Sci USA 92:5307–5311PubMedCrossRefGoogle Scholar
  26. Milich DR (1988) T- and B-cell recognition of hepatitis B viral antigens. Immunol Today 9:380–386PubMedCrossRefGoogle Scholar
  27. Moss B, Smith GL, Gerin JL, Purcell RH (1984) Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature 311:67–69PubMedCrossRefGoogle Scholar
  28. Murray K, Bruce SA, Hinnen A, et al. (1984) Hepatitis B virus antigens made in microbial cells immunize against viral infection. Embo J 3:645–650PubMedGoogle Scholar
  29. Prince AM (1981) The use of chimpanzees in biomedical research. In: US Department of Health and Human Services (ed) Trends in bioassay methodology in vivo, in vitro and mathematical approaches, vol 82, NIH, Bethesda, pp 81–98Google Scholar
  30. Purcell RH (1994) Hepatitis viruses: changing patterns of human disease. Proc Natl Acad Sci USA 91: 2401–2406PubMedCrossRefGoogle Scholar
  31. Purcell RH, Gerin JL (1975) Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees. Am J Med Sci 270:395–399PubMedCrossRefGoogle Scholar
  32. Purcell RH, Gerin JL (1987) Hepatitis B vaccines, past, present and future: lessons for AIDS vaccine development. In: Robinson W, Koike K, Will H (eds) Hepadna viruses, Alan R Liss, New York, pp 465–479Google Scholar
  33. Stephenne J (1988) Recombinant versus plasma-derived hepatitis B vaccines: issues of safety immuno- genicity and cost-eífectiveness. Vaccine 6:299–303PubMedCrossRefGoogle Scholar
  34. Thornton GB, Moriarty AM, Milich DR, Eichberg JW, Purcell RH, Gerin JL (1989) Protection of chimpanzees from hepatitis B virus infection after immunization with synthetic peptides: identification of protective epitopes in the pre-S region. In: Chanock RM, Lerner RA, Brown F, Ginsberg H (eds)Vaccines 89, Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 467–471Google Scholar
  35. Tiollais P, Buendia M-A (1991) Hepatitis B virus. Sci Amer 264:48–54CrossRefGoogle Scholar
  36. Valenzuela P, Medina A, Rutter WJ, Ammerer G, Hall BD (1982) Synthesis and assembly of hepatitis B virus surface antigen particles in yeast. Nature 298:347–350PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • H. L. Davis
    • 1
    • 2
  1. 1.Loeb Research InstituteOttawa Civic HospitalOttawaCanada
  2. 2.Faculties of Health Sciences and MedicineUniversity of OttawaCanada

Personalised recommendations